DiscoverStartupsLyell ImmunotherapyLyell Immunotherapy Funding Rounds, Valuation & Investors
Lyell Immunotherapy company logo
Lyell Immunotherapy
Is a next generation CAR-T cell company201-500 Employees
  • B2B
  • Public Stage
    Publicly traded company
  • Top Investors
    This company has received a significant amount of investment from top investors
View 1 job

Lyell Immunotherapy Funding

$50M
11 round
Lyell Immunotherapy is active in the following markets / industries: biotechnology and software engineering. The company has secured funding across 1 rounds, totaling in an amount of $50M. Their most recent funding was raised on July 25, 2025.

Funding Rounds

S
$50000000
SeedJul 2025$0 valuation
Back to People
Onwards to Jobs